Literature DB >> 1261607

Differences in the mode of exucative reaction between early phase and late phase of carrageenin-induced inflammation in rats.

W C Chang, S Tsurufiji.   

Abstract

Differences in the mode of vascular permeability change induced by some stimulants such as chemical mediators between the early phase and the late phase of the carrageenin-induced granulomatous inflammation were investigated with the aid of 131I-human serum albumin as an indicator for the measurement of vascular permeability. In the early pregranulomatous phase of the inflammation, histamine injection into the inflammation locus markedly elevated local vascular permeability, while prostaglandins E1 and E2 showed no effect. On the other hand, in the late phase of the inflammation, where permanent granuloma tissue had been formed, prostaglandins E1 and E2 significantly enhanced the local vascular permeability, while histamine was inert.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261607     DOI: 10.1016/0014-2999(76)90250-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Alterations in prostaglandin E1-induced blood flow changes in granulation tissue [proceedings].

Authors:  L D De Leve; M J Parnham; P R Saxena
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

2.  Time-dependent pro- and anti- inflammatory effects of prostaglandin (PG)E1 on experimental granulomata rats [proceedings].

Authors:  I L Bonta; M J Parnham
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

3.  Development of enhanced blood flow responses to prostaglandin E1 in carrageenan-induced granulation tissue.

Authors:  M J Parnham; L D de Leve; P R Saxena
Journal:  Agents Actions       Date:  1979-12

4.  Time-dependent stimulatory and inhibitory effects of prostaglandin E1 on exudative and tissue components of granulomatous inflammation in rats.

Authors:  I L Bonta; M J Parnham
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.